DK0921806T3 - Mannose-6-phosphat-præparat og anvendelse deraf til behandling af fibrøse lidelser - Google Patents

Mannose-6-phosphat-præparat og anvendelse deraf til behandling af fibrøse lidelser

Info

Publication number: DK0921806T3
Authority: DK; Denmark
Prior art keywords: mannose; treatment; phosphate preparation; fibrous disorders; fibrous
Prior art date: 1996-08-12

Application number

DK97934624T

Other languages

English (en)

Inventor

Mark William James Ferguson

Original Assignee

Btg Int Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-12

Filing date

1997-07-31

Publication date

2003-12-08

1997-07-31 Application filed by Btg Int Ltd filed Critical Btg Int Ltd

2003-12-08 Application granted granted Critical

2003-12-08 Publication of DK0921806T3 publication Critical patent/DK0921806T3/da

Links

NBSCHQHZLSJFNQ-QTVWNMPRSA-N D-Mannose-6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H]1O NBSCHQHZLSJFNQ-QTVWNMPRSA-N 0.000 title abstract 2
239000000725 suspension Substances 0.000 abstract 2
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
239000000499 gel Substances 0.000 abstract 1
229920002674 hyaluronan Polymers 0.000 abstract 1
229960003160 hyaluronic acid Drugs 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
238000010979 pH adjustment Methods 0.000 abstract 1
230000036573 scar formation Effects 0.000 abstract 1
230000029663 wound healing Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Ophthalmology & Optometry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Materials For Medical Uses (AREA)

DK97934624T 1996-08-12 1997-07-31 Mannose-6-phosphat-præparat og anvendelse deraf til behandling af fibrøse lidelser DK0921806T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9616896.8A GB9616896D0 (en)	1996-08-12	1996-08-12	Pharmaceutical compositions
PCT/GB1997/002076 WO1998006406A1 (en)	1996-08-12	1997-07-31	Mannose-6-phosphate composition and its use in treating fibrotic disorders

Publications (1)

Publication Number	Publication Date
DK0921806T3 true DK0921806T3 (da)	2003-12-08

Family

ID=10798358

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97934624T DK0921806T3 (da)	1996-08-12	1997-07-31	Mannose-6-phosphat-præparat og anvendelse deraf til behandling af fibrøse lidelser

Country Status (12)

Country	Link
EP (1)	EP0921806B1 (da)
JP (2)	JP4971534B2 (da)
AT (1)	ATE249225T1 (da)
AU (1)	AU721224B2 (da)
CA (1)	CA2261988C (da)
DE (1)	DE69724798T2 (da)
DK (1)	DK0921806T3 (da)
ES (1)	ES2206737T3 (da)
GB (1)	GB9616896D0 (da)
PT (1)	PT921806E (da)
WO (1)	WO1998006406A1 (da)
ZA (1)	ZA977151B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9616896D0 (en) *	1996-08-12	1996-09-25	British Tech Group	Pharmaceutical compositions
WO2004031379A1 (en) *	2002-10-01	2004-04-15	Unilever N.V.	Proteins having polysaccharidase activity
US9517023B2 (en)	2009-06-01	2016-12-13	Profusa, Inc.	Method and system for directing a localized biological response to an implant
GB0910078D0 (en) *	2009-06-11	2009-07-22	Renovo Ltd	Uses of mannose-6-phosphate
GB0916333D0 (en)	2009-09-17	2009-10-28	Renovo Ltd	Improvement of tendon repair
US10010272B2 (en)	2010-05-27	2018-07-03	Profusa, Inc.	Tissue-integrating electronic apparatus
JP5827999B2 (ja)	2010-10-06	2015-12-02	プロフューザ，インコーポレイティド	組織集積センサー
CN113274007B (zh)	2013-03-14	2024-10-18	普罗菲尤萨股份有限公司	用于校正光学信号的方法和装置
WO2014197786A2 (en)	2013-06-06	2014-12-11	Kintz Gregory J	Apparatus and methods for detecting optical signals from implanted sensors
US11331018B2 (en)	2016-12-22	2022-05-17	Profusa, Inc.	System and single-channel biosensor for and method of determining analyte value
GB201904469D0 (en)	2019-03-29	2019-05-15	Givaudan Sa	Cosmetic composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5244651A (en) *	1991-09-04	1993-09-14	Kao Corporation	Method of desensitizing hypersensitive dentin
GB9205800D0 (en) *	1992-03-17	1992-04-29	British Tech Group	Treatment of fibrotic disorders
GB9616896D0 (en) *	1996-08-12	1996-09-25	British Tech Group	Pharmaceutical compositions

1996
- 1996-08-12 GB GBGB9616896.8A patent/GB9616896D0/en active Pending
1997
- 1997-07-31 DE DE69724798T patent/DE69724798T2/de not_active Expired - Lifetime
- 1997-07-31 CA CA002261988A patent/CA2261988C/en not_active Expired - Fee Related
- 1997-07-31 PT PT97934624T patent/PT921806E/pt unknown
- 1997-07-31 ES ES97934624T patent/ES2206737T3/es not_active Expired - Lifetime
- 1997-07-31 AU AU37769/97A patent/AU721224B2/en not_active Ceased
- 1997-07-31 AT AT97934624T patent/ATE249225T1/de active
- 1997-07-31 EP EP97934624A patent/EP0921806B1/en not_active Expired - Lifetime
- 1997-07-31 JP JP50947298A patent/JP4971534B2/ja not_active Expired - Fee Related
- 1997-07-31 WO PCT/GB1997/002076 patent/WO1998006406A1/en not_active Ceased
- 1997-07-31 DK DK97934624T patent/DK0921806T3/da active
- 1997-08-11 ZA ZA977151A patent/ZA977151B/xx unknown
2009
- 2009-05-29 JP JP2009129987A patent/JP2009221220A/ja active Pending

Also Published As

Publication number	Publication date
WO1998006406A1 (en)	1998-02-19
ZA977151B (en)	1999-02-11
DE69724798T2 (de)	2004-07-15
JP2000516603A (ja)	2000-12-12
JP2009221220A (ja)	2009-10-01
JP4971534B2 (ja)	2012-07-11
EP0921806B1 (en)	2003-09-10
EP0921806A1 (en)	1999-06-16
ES2206737T3 (es)	2004-05-16
PT921806E (pt)	2003-12-31
GB9616896D0 (en)	1996-09-25
DE69724798D1 (de)	2003-10-16
AU3776997A (en)	1998-03-06
CA2261988A1 (en)	1998-02-19
ATE249225T1 (de)	2003-09-15
CA2261988C (en)	2006-11-07
AU721224B2 (en)	2000-06-29

Publication	Publication Date	Title
DE69302823D1 (de)	1996-06-27	Kieselsäuresole, verfahren zur herstellung von kieselsäuresolen und verwendung von diesen solen
ATE207753T1 (de)	2001-11-15	Wundheilmittel
DE69929810D1 (de)	2006-04-20	Verwendung von tetracyclinderivaten zur steigerung der interleukin-10 produktion
MY121294A (en)	2006-01-28	Novel hexanoic acid derivatives.
EP1007556A4 (en)	2000-06-14	TROPONIN SUB-UNITS AND FRAGMENTS FOR USE AS INHIBITORS OF ANGIOGENESIS
DE3580769D1 (de)	1991-01-17	Zusammensetzungen und verfahren zur wundheilung.
PT921806E (pt)	2003-12-31	Composicao de manose-6-fosfato e seu uso no tratamento de desordens fibroticas
PT862452E (pt)	2004-04-30	Formulacao de estabilizacao para o ngf
MY133125A (en)	2007-10-31	Novel dihydroxyhexanoic acid derivatives
ATE321045T1 (de)	2006-04-15	Methoden und zusammensetzungen zur behandlung von schmerzen
BG104958A (bg)	2001-07-31	Стабилни състави, съдържащи левосимендан и алгинова киселина
ATE275964T1 (de)	2004-10-15	Verwendung von betalycan zur verminderung der narbenbildung
YU42401A (sh)	2003-12-31	Supstituisani heterociklični acil-tripeptidi korisni kao modulatori receptora trombina
ATE189392T1 (de)	2000-02-15	Hypocholesterolemische, antiatherosklerotische und hypotriglyceridemische verwendung von aminoacetylmercapto derivaten
ATE77952T1 (de)	1992-07-15	Verwendung von 1,4-dihydropyridinderivaten.
DE3751059D1 (de)	1995-03-23	Verwendung von Corticosteroide zur Verringerung von postoperativen Schmerzen.
EP0691347A4 (en)	1997-07-30	GROWTH SUBSTANCE FOR LIVER PARENCHYM CELLS